Find clinical trials for Incyte. Search for Incyte clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 30
New
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
for
Renal Impairment
Location: Miami Lakes FL, Orlando FL
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 70+
Code: NCT07559396
Phase1, Recruiting
New
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
for
Hepatic Insufficiency, Liver Diseases
Location: Orlando FL, San Antonio TX, Chandler AZ
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 70+
Code: NCT07559474
Phase1, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Montreal, Toronto
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05936359
Phase1, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase1, Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Chattanooga TN, Billings MT, Los Angeles CA
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
for
Solid Tumors, Hematologic Malignancies
Location: Nashville TN, Houston TX, Duarte CA
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07195916
Phase1, Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population